Literature DB >> 31102461

Classification of breast tissue expander infections: Back to the basics.

Franca S Kraenzlin1, Heather Saunders2, Oluseyi Aliu1, Damon Cooney1, Gedge D Rosson1, Justin M Sacks1, Kristen Broderick1, Michele A Manahan1.   

Abstract

BACKGROUND: Infections following tissue expander (TE) placement are frequent complications in breast reconstruction. While breast surgery is a clean case, implant-based breast reconstruction has rates of infection up to 31%, decidedly higher than the typical 1% to 2% rate of surgical site infections (SSI). Few authors use the Center for Disease Control's (CDC) SSI definition for TE infections. We highlight how adoption of a consistent definition of TE infection may change how infections are researched, categorized, and ultimately managed.
METHODS: Two researchers with definitional discrepancies of infection performed an independent analysis of all postmastectomy patients receiving TEs (n = 175) in 2017.
RESULTS: Researcher One, using a clinical definition, delineated an infection rate of 19.4%. Antibiotics alone successfully treated 50% of cases. Researcher Two found an infection rate of 13.7% using CDC criteria. These infections were further delineated by a SSI rate of 6.3% and a TE infection rate post port access of 7.4%. Only 45.5% SSI's and 15.4% of TE infections were salvaged with antibiotics alone.
CONCLUSIONS: Rigorous adoption of CDC criteria for infection characterization in published research will help standardize the definition of infection and allow surgeons to create evidence-based infection prevention regimens.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast reconstruction; tissue expander infections; tissue expander-based breast reconstruction

Mesh:

Substances:

Year:  2019        PMID: 31102461     DOI: 10.1002/jso.25500

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Tissue Expander-Based Breast Reconstruction at a Major Safety-Net Hospital: Managing the Outsized Risk of Infection.

Authors:  Lindsey N Urquia; Silas P Henderson; Jordyn T Farewell; Sofia Duque; Maycie Garibay; Julia Nevin; Andrew Y Zhang
Journal:  Aesthet Surg J Open Forum       Date:  2022-05-02

2.  Microbiology of breast tissue expanders.

Authors:  Maja Molska; Mateusz Wichtowski; Dawid Murawa
Journal:  Contemp Oncol (Pozn)       Date:  2022-01-05

3.  Breast Reconstruction Completion in the Obese: Does Reconstruction Technique Make a Difference in Its Achievement?

Authors:  Christine Velazquez; Robert C Siska; Ivo A Pestana
Journal:  J Reconstr Microsurg       Date:  2021-03-31       Impact factor: 2.873

4.  Clinical implications of restrictions in criteria for defining surgical site infections after mastectomy.

Authors:  Antoinette A A Bediako-Bowan; David K Warren; Katelin B Nickel; Victoria J Fraser; Margaret A Olsen
Journal:  Infect Control Hosp Epidemiol       Date:  2020-11-17       Impact factor: 6.520

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.